Caspofungin
In the US, Caspofungin (caspofungin systemic) is a member of the drug class echinocandins and is used to treat Aspergillosis - Invasive, Candida Infections - Systemic, Esophageal Candidiasis and Febrile Neutropenia.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J02AX04
CAS registry number (Chemical Abstracts Service)
0162808-62-0
Chemical Formula
C52-H88-N10-O15
Molecular Weight
1093
Therapeutic Category
Antifungal agent
Chemical Name
(4R,5S)-5-[(2-Aminoethyl)amino]-N²-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6->1)-peptide (WHO)
Foreign Names
- Caspofunginum (Latin)
- Caspofungin (German)
- Caspofungine (French)
- Caspofungina (Spanish)
Generic Names
- Caspofungin (OS: BAN)
- Caspofungin Acetate (OS: USAN, BAN)
- L 743872 (IS)
- MK 991 (IS: Merck)
Brand Names
- Cancidas
Merck, Peru; Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Italy; Merck Sharp & Dohme, Latvia; Merck Sharp & Dohme, Tunisia; MSD, South Africa; HAEMATO pharm, Austria; Merck, Iceland; Merck, South Korea; Merck, United States; Merck Frosst, Canada; Merck Sharp & Dohme, Argentina; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Aruba; Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Barbados; Merck Sharp & Dohme, Belgium; Merck Sharp & Dohme, Brazil; Merck Sharp & Dohme, Bahamas; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, China; Merck Sharp & Dohme, Costa Rica; Merck Sharp & Dohme, Czech Republic; Merck Sharp & Dohme, Finland; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Guatemala; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Honduras; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Hungary; Merck Sharp & Dohme, Ireland; Merck Sharp & Dohme, Israel; Merck Sharp & Dohme, Jamaica; Merck Sharp & Dohme, Cayman Islands; Merck Sharp & Dohme, Lithuania; Merck Sharp & Dohme, Mexico; Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, Nicaragua; Merck Sharp & Dohme, Netherlands; Merck Sharp & Dohme, Norway; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Panama; Merck Sharp & Dohme, Philippines; Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Romania; Merck Sharp & Dohme, Serbia; Merck Sharp & Dohme, Russian Federation; Merck Sharp & Dohme, Singapore; Merck Sharp & Dohme, Slovenia; Merck Sharp & Dohme, Slovakia; Merck Sharp & Dohme, El Salvador; Merck Sharp & Dohme, Thailand; Merck Sharp & Dohme, Turkey; Merck Sharp & Dohme, Trinidad & Tobago; Merck Sharp & Dohme, Taiwan; Merck Sharp & Dohme, Venezuela; Merck Sharp & Dohme-Chibret, France; Merck Sharp & Dome, Dominican Republic; MSD, Switzerland; MSD, Denmark; MSD, Sweden - CANCIDAS
Merck Sharp & Dohme, Germany - Candidas
Merck Sharp & Dohme, Australia - Intravenous Infusion Cancidas
Merck, United States
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
